Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-10-15

FDA Approved: FOSPHENYTOIN SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved a supplemental application for Fosphenytoin Sodium from Amneal Pharmaceuticals LLC, adding an updated approval for this generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fosphenytoin Sodium (fosphenytoin sodium)

Snippet

SUPPL AP for FOSPHENYTOIN SODIUM (FOSPHENYTOIN SODIUM)